# Impact of Structural Features on the Antioxidant Activity of Organofluorine Diaryl Hydrazones

**Authors:** Zsuzsanna K. Zsengellér, Maxim Mastyugin, Adrianna R. Fusco, Bernadett R. Vlocskó, Coryn Ferguson, Diana Pintye, Hamad Nasim, Saira Salahuddin, Brett C. Young, Béla Török, Marianna Török

PMC · DOI: 10.3390/molecules31010078 · Molecules · 2025-12-24

## TL;DR

This study explores how the structure of organofluorine diaryl hydrazones affects their antioxidant activity, aiming to alleviate preeclampsia symptoms by reducing oxidative stress.

## Contribution

The paper introduces new organofluorine diaryl hydrazones with strong antioxidant properties and evaluates their effectiveness in reducing sFLT-1 release in a preeclampsia model.

## Key findings

- Compounds 2, 3, 5, and 6 showed excellent antioxidant activity in DPPH, ABTS, and ORAC assays.
- Compounds 5 and 6 were more effective in reducing sFLT-1 release than compounds 2 and 3 in an in vitro model.
- Density functional theory calculations revealed insights into the electronic structures and radical stabilization of the compounds.

## Abstract

Preeclampsia (PE) affects 2–8% of pregnancies, yet it lacks curative treatment options. Oxidative stress caused by the release of reactive oxygen and nitrogen species (ROS/RNS) in the placenta is common in abnormal placental development. It can cause downstream signaling and the formation of anti-angiogenic factors, e.g., soluble fms-like tyrosine kinase 1 (sFLT-1), leading to symptoms of PE, such as hypertension, proteinuria, and, in severe cases, eclampsia. Mitochondria-targeted antioxidants were developed to reduce oxidative stress and alleviate PE symptoms. Ten organofluorine diaryl hydrazones were designed as potential antioxidants, synthesized, and tested for their activity using the 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), and oxygen radical absorbance capacity (ORAC) assays. Compounds 2, 3, 5, and 6 showed excellent antioxidant capacity in all three assays and were tested in an in vitro human trophoblast cell culture system mimicking PE in which the cells were exposed to oxidative stress inducing the release of sFLT-1. The anti-angiogenic factor sFLT-1 was greatly reduced in cells treated with antioxidants. Compounds 5 and 6 were more effective in preventing sFLT-1 release than 2 and 3. Density functional theory calculations of the electronic structures of compounds 2, 5, and 6 were conducted at the M06-2X/6-311G+(d,p) level to further understand the reactivity profile of these molecules. The electron density of delocalized bonds (EDDB(r)) was calculated to analyze the effect of delocalization on radical stabilization.

## Linked entities

- **Proteins:** Flt1 (FMS-like tyrosine kinase 1)
- **Chemicals:** ABTS (PubChem CID 35688)
- **Diseases:** preeclampsia (MONDO:0005081), eclampsia (MONDO:0001754)

## Full-text entities

- **Genes:** FLT1 (fms related receptor tyrosine kinase 1) [NCBI Gene 2321] {aka FLT, FLT-1, VEGFR-1, VEGFR1}
- **Diseases:** PE (MESH:D011225), hypertension (MESH:D006973), proteinuria (MESH:D011507), eclampsia (MESH:D004461)
- **Chemicals:** Organofluorine Diaryl Hydrazones (-), oxygen (MESH:D010100), RNS (MESH:D011886), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (MESH:C002502), 2,2-diphenyl-1-picrylhydrazyl (MESH:C004931)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12786584/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12786584/full.md

## References

52 references — full list in the complete paper: https://tomesphere.com/paper/PMC12786584/full.md

---
Source: https://tomesphere.com/paper/PMC12786584